+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Professor Jonathan Ledermann
BSc MD FRCP
Ovarian cancer (chemotherapy)
Professor Jonathan Ledermann graduated in medicine at UCL and UCH Medical School, and subsequently trained in medical oncology at UCH, Charing Cross Hospital London, and the Princess Margaret Hospital Toronto, before moving to UCL as a consultant in 1990. He specialises in the treatment of gynaecological and colorectal cancers and is the lead medical oncologist for gynaecological cancers in the North London Cancer Network, where he is also the lead for clinical research. His other research interests are in clinical trials and he is head of the UCL Cancer Trials Centre, one of the NCRI-accredited national cancer trials centres funded by research grants from Cancer Research UK.Professor Ledermann has developed and led several national and international trials in gynaecological cancer and is currently leading two trials with novel drugs in ovarian cancer. He is a member of the NCRI clinical studies group for gynaecological cancers. He is also one of the UK representatives on the GCIG (Gynaecological Cancer InterGroup), an international organisation for trials and treatment of gynaecological cancers.Professor Ledermann has many publications to his name in the field of ovarian and colorectal cancer, serves on editorial boards for professional journals and is a medical advisor to several pharmaceutical companies. He is an acknowledged international expert in ovarian cancer and has lectured widely on his research.
To Make an appointment, call HCA on +44(0)20 7079 4399
or click here
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.